Genetically enhanced T lymphocytes and the intensive care unit

Chimeric antigen receptor-modified T cells (CAR-T cells) and donor lymphocyte infusion (DLI) are important protocols in lymphocyte engineering. CAR-T cells have emerged as a new modality for cancer immunotherapy due to their potential efficacy against hematological malignancies. These genetically mo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Tat, Tiberiu, Li, Huming, Constantinescu, Catalin-Sorin, Onaciu, Anca, Chira, Sergiu, Osan, Ciprian, Pasca, Sergiu, Petrushev, Bobe, Moisoiu, Vlad, Micu, Wilhelm-Thomas, Berce, Cristian, Tranca, Sebastian, Dima, Delia, Berindan-Neagoe, Ioana, Shen, Jianliang, Tomuleasa, Ciprian, Qian, Liren
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2018
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5893262/
https://ncbi.nlm.nih.gov/pubmed/29662667
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24637
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars